First-Line Tislelizumab Plus Chemo Elicits Deep Responses Linked to OS Benefits in ESCC
OS benefits with tislelizumab plus chemotherapy were comparable between early and late responders in the phase 3 RATIONALE-306 study in patients with ESCC.
Related Articles
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
An integrated intervention had the greatest impact in a randomized trial
First-Line Nivolumab/Chemo Generates Long-Term Survival Benefits in Gastric/GEJ/Esophageal Cancer
Frontline nivolumab plus chemotherapy elicited clinically meaningful long-term survival benefits vs chemotherapy alone in advanced gastric/GEJ cancer.
Trastuzumab/Pertuzumab/Chemo Does Not Confer Response Advantage in Gastric/GEJ Cancer
Trastuzumab/pertuzumab/chemotherapy was associated with higher rates of toxicity and no mpRR improvement vs chemotherapy alone in HER2+ gastric cancer.
ISLB Global Survey: Oncologist Attitudes and Practices on Liquid Biopsy
About the survey This survey aims to evaluate oncologists’ attitudes, practices, and barriers to the use of liquid biopsy in clinical care. Your participation in…
Fox Chase Cancer Center Welcomes Weiran Feng
PHILADELPHIA (January 21, 2025) — Fox Chase Cancer Center is pleased to announce the hiring of Weiran Feng, PhD, as an Assistant Professor in the…
Collection Details : Oncology Times
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
First Dose of CD38-Targeting CAR T-Cell Therapy Administered in AML
The first patient with relapsed/refractory acute myeloid leukemia has received KJ-C2320, an allogeneic CAR T-cell therapy targeting CD38 and developed using the THANK-uCAR platform, in…
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma
This randomized phase III trial aimed to determine whether treatment with cisplatin and volume-directed radiation followed by carboplatin and paclitaxel for four cycles (chemoradiotherapy [C-RT])…
Program Guide – ASCO Meeting Program Guide
Jonathan Strosberg H. Lee Moffitt Cancer Center and Research Institute Jonathan Strosberg , Tyler Zemla , Susan Geyer , Michael Knopp , Spencer Behr ,…
